Passage Bio, Inc. (PASG)
3.46
-0.05
(-1.42%)
USD |
NASDAQ |
Nov 05, 16:00
Passage Bio Price : 3.46 for Nov. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 3.52 | 3.56 | 3.390 | 3.46 | 28146.00 |
| Nov 04, 2026 | 3.459 | 3.69 | 3.45 | 3.51 | 25269.00 |
| Nov 03, 2026 | 3.40 | 3.48 | 3.33 | 3.40 | 7687.00 |
| Nov 02, 2026 | 3.45 | 3.55 | 3.32 | 3.32 | 11137.00 |
| Oct 30, 2026 | 3.48 | 3.605 | 3.44 | 3.45 | 7173.00 |
| Oct 29, 2026 | 3.33 | 3.83 | 3.33 | 3.52 | 16688.00 |
| Oct 28, 2026 | 3.30 | 3.565 | 3.30 | 3.33 | 8034.00 |
| Oct 27, 2026 | 3.31 | 3.40 | 3.31 | 3.35 | 3993.00 |
| Oct 26, 2026 | 3.365 | 3.365 | 3.359 | 3.359 | 1634.00 |
| Oct 23, 2026 | 3.63 | 3.63 | 3.345 | 3.37 | 21535.00 |
| Oct 22, 2026 | 3.422 | 3.86 | 3.422 | 3.51 | 43942.00 |
| Oct 21, 2026 | 3.56 | 3.59 | 3.47 | 3.59 | 2906.00 |
| Oct 20, 2026 | 3.454 | 3.68 | 3.454 | 3.60 | 5660.00 |
| Oct 19, 2026 | 3.50 | 3.60 | 3.43 | 3.58 | 10903.00 |
| Oct 16, 2026 | 3.61 | 3.76 | 3.37 | 3.50 | 16804.00 |
| Oct 15, 2026 | 3.60 | 3.92 | 3.60 | 3.60 | 15936.00 |
| Oct 14, 2026 | 3.64 | 3.93 | 3.62 | 3.66 | 7842.00 |
| Oct 13, 2026 | 4.46 | 4.46 | 3.63 | 3.64 | 14219.00 |
| Oct 12, 2026 | 3.61 | 4.55 | 3.60 | 4.55 | 76402.00 |
| Oct 09, 2026 | 3.83 | 3.83 | 3.61 | 3.69 | 12111.00 |
| Oct 08, 2026 | 3.77 | 3.83 | 3.62 | 3.78 | 15793.00 |
| Oct 07, 2026 | 4.00 | 4.05 | 3.762 | 3.855 | 14064.00 |
| Oct 06, 2026 | 4.13 | 4.290 | 4.08 | 4.08 | 6574.00 |
| Oct 05, 2026 | 4.05 | 4.19 | 4.05 | 4.09 | 17933.00 |
| Oct 02, 2026 | 4.29 | 4.44 | 4.11 | 4.12 | 17049.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.89 |
| Alnylam Pharmaceuticals, Inc. | 157.21 |
| Anika Therapeutics, Inc. | 16.95 |
| Savara, Inc. | 4.55 |
| Vericel Corp. | 50.95 |
Price Related Metrics
| PEG Ratio | -0.0063 |
| Price to Book Value | 2.499 |
| Earnings Yield | -326.9% |
| Market Cap | 11.13M |
| PEGY Ratio | -0.0063 |